Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03849963

Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain

Status
Recruiting
Phase
Study type
Observational
Enrollment
28 (estimated)
Sponsor
University of Texas Southwestern Medical Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Investigators propose to develop hyperpolarized \[13C\]-labeled pyruvate as potential imaging probes to assess two essential in vivo processes in cerebral metabolism: oxidative metabolism and synthesis of a neurotransmitter in this observational study.

Detailed description

Investigators will perform a pilot study to test the translational feasibility by evaluating sensitivity and repeatability of hyperpolarized \[1-13C\]pyruvate and \[2-13C\]pyruvate in healthy human subjects (n =10 each). Each subject will be imaged twice using the same hyperpolarized substrate with an interval (\<45min) between the injections to evaluate repeatability. Finally, eight subjects will be imaged with both hyperpolarized \[1-13C\]pyruvate and \[2-13C\]pyruvate for comparison.

Conditions

Timeline

Start date
2030-07-30
Primary completion
2030-12-31
Completion
2030-12-31
First posted
2019-02-21
Last updated
2026-03-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03849963. Inclusion in this directory is not an endorsement.